← Back
$NRIX All transactions

Nurix Therapeutics, Inc.

A

$ Value

$0

Shares

20,000

Price

$0

Filed

Oct 23

Insider

Name

Hansen Gwenn

Title

Chief Scientific Officer

CIK

0001817160

Roles

Officer

Transaction Details

Transaction Date

2025-10-14

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

20,000

Footnotes

Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock. | The RSUs will vest on the second anniversary of the date of grant, subject to the Reporting Person's continuous services to the Issuer from the date of grant through such vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person following vesting. | RSUs do not expire; they either vest or are canceled prior to the vest date.

Filing Info

Accession No.

0001817160-25-000003

Form Type

4

Issuer CIK

0001549595

Hansen Gwenn's History

Date Ticker Type Value
2026-02-10 NRIX A $0
2026-02-10 NRIX A $0
2026-02-03 NRIX M $26K
2026-02-03 NRIX M $0
2026-01-30 NRIX M $0
2026-01-30 NRIX M $0
2026-01-30 NRIX M $0
2026-01-30 NRIX M $0
2026-01-30 NRIX $80K
2026-01-30 NRIX $2K

Other Insiders at NRIX (90d)

Insider Bought Sold Last
SANDS ARTHUR T
President, CEO
2026-02-10
Hansen Gwenn
Chief Scientific Officer
$81K 2026-02-10
Ring Christine
Chief Legal Officer
$561K 2026-04-02
van Houte Hans
Chief Financial Officer
$61K 2026-02-10